Literature DB >> 2944772

An alternative to in vitro fertilization-embryo transfer: the successful transfer of human oocytes and spermatozoa to the distal oviduct.

J S Nemiro, R W McGaughey.   

Abstract

In vitro fertilization-embryo transfer (IVF-ET) for treatment of irreparable tubal damage provides a means for otherwise hopelessly infertile couples to obtain offspring. Recently a simpler and less expensive procedure was applied as an alternative to IVF-ET to patients with at least one patent fallopian tube. This procedure employs stimulated ovarian cycles, washed and cultured sperm, and laparoscopic aspiration of oocytes. Recovered oocytes and sperm are deposited in the ampulla of the oviduct by means of a catheter. From February 1 to September 28, 1985, 137 cycles yielded 60 laparoscopies (51 patients). Elevated human chorionic gonadotropin observed in 18 cases was confirmed in 12 cases by ultrasound. Nine uterine pregnancies continued with no tubal pregnancy. Success is comparable for this new procedure and IVF-ET. The results suggest that many IVF-ET patients should be offered the simpler and less expensive option of tubal transfer (TT).

Entities:  

Mesh:

Year:  1986        PMID: 2944772     DOI: 10.1016/s0015-0282(16)49642-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  The detection of blood contamination in human follicular fluid.

Authors:  P F Levay; C Huyser; F L Fourie; D J Rossouw
Journal:  J Assist Reprod Genet       Date:  1997-04       Impact factor: 3.412

2.  Gamete intrafallopian transfer vs superovulation with intrauterine insemination for the treatment of infertility.

Authors:  C R Kaplan; D L Olive; V Sabella; R H Asch; J P Balmaceda; R M Riehl; T R Groff; W N Burns; R S Schenken
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-10

Review 3.  Critical reappraisal of the clinical effectiveness of different methods of assisted fertilization.

Authors:  G B Melis; F Strigini; V Mais; A M Paoletti; L Olivieri; D Antinori; S Guerriero; A de Ruggiero; F D Petacchi; P Fioretti
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.